Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Washington
With
National Cancer Institute (NCI)
OUTLINE:
Participants receive web-based or hard-copy questionnaires and saliva collection kits via mail or in person. Participants also provide saliva samples to be mailed back to Color Genomics for genetic testing once complete. Participants then receive phone-based genetic counseling if they are identified to have an inherited mutation in a deoxyribonucleic acid (DNA) repair gene. All participants have access to phone-based genetic counseling whether or not they are not found to have a mutation.
After study completion, participants are followed up at 6 months.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent form (ICF) providing agreement for germline genetic testing, use and release of health and research trial information
Documented evidence of metastatic prostate cancer;
* Oncologist note within 4 months
* All computed tomography (CT), bone, positron emission tomography (PET) scan reports within 12 months
* All prostate-specific antigen (PSA) values within 12 months
* All available pathology reports from diagnosis, prostatectomy, and/or metastatic biopsy
Willingness to provide basic demographic information, family cancer history, and treatment history
Willingness and ability to complete patient reported outcomes questionnaire (on-line or hard copy) at enrollment, and at 6-month follow-up
Willingness and ability to provide saliva sample
Study team members
You may not be if
Unable or unwilling to provide all of the necessary information for eligibility, e.g. decisionally impaired
Clareo Health | Genetic Testing for Men With Metastatic Prostate Cancer
